Related Experiment Video
Updated: Mar 3, 2026
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Understanding mitotane mode of action
U Waszut1, P Szyszka1, D Dworakowska2,3,4
1Department of Nuclear Medicine, Medical University of Gdansk, Gdansk, Poland.
Abstract:
Adrenocortical carcinoma is a rare disease with poor prognosis. Mitotane is the most effective agent in post-operative treatment (or when inoperable). It selectively limits growth and bioactivity of adrenal tissue. Despite 60 years of use, the basis for its action has yet to be convincingly established. This review summarizes current knowledge of mitotane effects, based on studies on adrenal tissue and primary cell cultures, with emphasis on more recent studies of cell lines. We consider features of the adrenal cortex that might explain mitotane selectivity, and review effects on non-adrenal cells. Since the most clear-cut mitotane effects have been observed for mitochondria, this topic is the core of the review. Mitochondria present unique characteristics in steroidogenic tissue and are known to be important in malignancy development and apoptosis. We look at the evidence for mitotane activation within mitochondria, its impact on mitochondrial energy metabolism and other cellular processes as well as on downstream effects in the cell, such as apoptosis initiation. Further genomic and proteomic investigative studies are likely to yield useful results.
Insights
Mitotane is a key treatment for adrenocortical carcinoma, selectively targeting adrenal tissue. This review explores its mitochondrial mechanisms, revealing insights into its therapeutic effects and potential for future research.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a poor prognosis.
- Mitotane is the primary therapeutic agent for ACC, particularly in post-operative and inoperable cases.
- The precise mechanism of mitotane's action remains incompletely understood despite decades of clinical use.
Purpose of the Study:
- To review current knowledge on mitotane's effects on adrenal tissue and cell lines.
- To explore the basis for mitotane's selectivity towards adrenal tissue.
- To focus on the role of mitochondria in mitotane's mechanism of action.
Main Methods:
- Review of existing literature on mitotane's effects.
- Analysis of studies on adrenal tissue, primary cell cultures, and cancer cell lines.
- Examination of mitochondrial function and cellular processes affected by mitotane.
Main Results:
- Mitotane exhibits selective effects on adrenal tissue, with mitochondria being a primary target.
- Evidence suggests mitotane activation within mitochondria, impacting energy metabolism and cellular processes.
- Mitotane influences downstream cellular events, including the initiation of apoptosis.
Conclusions:
- Mitochondrial mechanisms are central to mitotane's therapeutic effects in adrenocortical carcinoma.
- Understanding mitotane's impact on mitochondrial function offers avenues for improved ACC treatment strategies.
- Further genomic and proteomic studies are warranted to fully elucidate mitotane's action.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:10Drugs that Destabilize Microtubules
02:38Mitogens and the Cell Cycle
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...